// App-Quantinova.ai

PB0226 : Assay of the factor VIIIa mimetic, Mim8, using one-stage clotting assay requires a product-specific reference material

Researchers

Presenter

  • H. Wilmot

Principal Investigators

  • M. Ezban

  • E. Gray

Medical Centers

  • MHRA-NIBSC, Potters Bar, England, United Kingdom

  • Novo Nordisk A/S, Måløv, Hovedstaden, Denmark

  • National Institute for Biological Standards and Control, Medicines and Healthcare products Regulatory Agency, Potters Bar, England, United Kingdom

Locations

  • United Kingdom

  • Denmark

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Activated partial thromboplastin time

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved